Saven Technologies Limited (BOM:532404)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	484	459	691	390	456	307
Market Cap Growth	-33.62%	-33.62%	77.13%	-14.44%	48.32%	129.68%
Enterprise Value	416	386	594	323	353	235
Last Close Price	44.47	42.15	61.67	33.84	37.70	24.06
PE Ratio	18.68	17.69	27.70	10.45	13.77	14.91
PS Ratio	3.38	3.21	5.24	2.59	4.22	3.92
PB Ratio	2.41	2.28	3.74	2.19	2.85	2.04
P/TBV Ratio	2.41	2.29	3.75	2.20	2.86	2.05
P/FCF Ratio	-	-	29.98	9.86	-	23.21
P/OCF Ratio	33.90	32.13	23.62	9.48	646.55	20.63
EV/Sales Ratio	2.90	2.70	4.51	2.14	3.27	3.00
EV/EBITDA Ratio	13.68	12.70	22.49	6.96	10.87	12.03
EV/EBIT Ratio	14.79	13.72	24.53	7.30	11.48	13.08
EV/FCF Ratio	-299.79	-	25.77	8.15	-	17.76
Asset Turnover	0.71	0.71	0.69	0.85	0.66	0.51
Quick Ratio	12.75	12.75	11.18	12.08	11.17	11.63
Current Ratio	13.03	13.03	11.61	12.45	11.57	12.03
Return on Equity (ROE)	13.44%	13.44%	13.74%	22.05%	21.28%	14.16%
Return on Assets (ROA)	8.71%	8.71%	7.94%	15.52%	11.68%	7.24%
Return on Capital (ROIC)	9.11%	9.11%	8.34%	16.32%	12.35%	7.72%
Return on Capital Employed (ROCE)	14.00%	14.00%	13.10%	24.80%	19.20%	11.90%
Earnings Yield	5.36%	5.65%	3.61%	9.56%	7.26%	6.71%
FCF Yield	-0.29%	-0.30%	3.34%	10.15%	-1.08%	4.31%
Dividend Yield	3.39%	3.56%	3.24%	5.91%	5.30%	4.16%
Payout Ratio	62.96%	62.96%	87.25%	58.33%	65.74%	52.78%
Buyback Yield / Dilution	-0.11%	-0.11%	-	-	-	-
Total Shareholder Return	3.28%	3.45%	3.24%	5.91%	5.30%	4.16%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.